the risk of jaw bone damage while taking Fosamax or other bisphosphonates

August 2006

Lots of worried patients are asking about the risk of jaw bone damage while taking Fosamax or other bisphosphonates.

Questions about osteonecrosis of the jaw have really picked up since we alerted you to this rare problem last year.

The incidence is very low for patients taking ORAL Fosamax, Actonel, or Boniva for osteoporosis. It's probably less than 1 case per 100,000 patients per year.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote